Can't sign in? Forgot your password? Enter your email address below and we will send you the reset instructions If the address matches an existing account you will receive an email with instructions to reset your password.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ank Agarwal
Consumer Risk in the Compounded GLP-1 Boom: Why Compounded GLP-1s Demand Urgent Public Health Action
A Personalized Mining Algorithm for Grassroots Network Data Based on Deep Learning
Submitted: 09 January 2026 You are already at the latest version To enhance the accuracy and efficiency of mining grassroots network data and to better support practical applications, this study proposes a personalized mining algorithm for grassroots network data based on deep learning. A multi-module neural network architecture is designed to process, filter, and transform raw grassroots network data.
Why rapid weight loss drugs may not be the health solution they seem [PODCAST]
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes! Join us in this episode as we talk with health reporter Martha Rosenberg about the complex dynamics behind obesity, junk food advertising, and the surge of new semaglutide-based weight loss drugs. We explore the implications of these drugs on public health, their potential long-term side effects, and the societal and economic impact of prioritizing quick fixes over sustainable health solutions.
Challenges With Relying on Body Fat and Weight Values for Obesity
Challenges With Relying on Body Fat and Weight Values for Obesity Body Composition in Anti-Obesity Medication Trials Ank A. Agarwal, BA; Aditya Narayan, BS; Fatima Cody Stanford, MD, MPH, MPA, MBA Challenges With Relying on Body Fat and Weight Values for Obesity—Reply Aditya Narayan, BS; Ank A.
Challenges With Relying on Body Fat and Weight Values for Obesity-Reply
Challenges With Relying on Body Fat and Weight Values for Obesity—Reply In Reply We express our gratitude to Kahn and Xiao for their thoughtful engagement with our Viewpoint on including fat loss measurements alongside weight as primary outcomes in clinical trials for anti-obesity medications.1 We happily maintain an ongoing dialogue with the medical community regarding the challenges and evolving methodologies in obesity treatment.
Challenges With Relying on Body Fat and Weight Values for Obesity
Challenges With Relying on Body Fat and Weight Values for Obesity Body Composition in Anti-Obesity Medication Trials Ank A. Agarwal, BA; Aditya Narayan, BS; Fatima Cody Stanford, MD, MPH, MPA, MBA Challenges With Relying on Body Fat and Weight Values for Obesity—Reply Aditya Narayan, BS; Ank A.
Body Composition in Anti-Obesity Medication Trials
Body Composition in Anti-Obesity Medication Trials—Beyond Scales Obesity is the world’s most prevalent chronic disease and has increasingly been recognized as a global public health challenge. It has alarming health effects and burdens health care systems globally. From 2013 to 2016, approximately half of US adults undertook weight loss initiatives, reflecting widespread concerns about weight and efforts toward healthier living.
Beyond the headlines: the truth about weight loss drugs [PODCAST]
Subscribe to The Podcast by KevinMD. Catch up on old episodes! We sit down with David Ahn, an endocrinologist. Join us as we delve into the impact of weight-loss drugs, the role of incretin medications, and their potential to reshape our approach to obesity and overall health. David Ahn is an endocrinologist and chief of diabetes services, Hoag Memorial Hospital Presbyterian, Newport Beach, CA.
How to sell your losing stocks to reduce taxes
Defining tax loss selling Tax loss selling, also known as tax-loss harvesting, is a strategy employed by investors to offset capital gains and reduce their taxable income. This approach involves selling stocks or other securities that have experienced losses to counterbalance capital gains realized throughout the year. By doing so, investors aim to mitigate their tax liability and potentially improve their after-tax returns. Mechanics of tax loss selling Identifying losses.
What we have to gain from weight loss drugs
Twenty years ago, the headlines were grim. It was common for studies to warn: “Rising childhood obesity will decrease life expectancy.” In large part, those predictions came true. The rise in obesity – both in children and adults – has correlated to a catastrophic rise in chronic disease that continues to affect life expectancy, cost of care, and quality of life.
AI in health care: Could it be an unexpected catalyst for physician burnout?
Artificial intelligence (AI) has rapidly ingratiated itself in the health care landscape, emerging as a powerful tool with the potential to revolutionize various aspects of clinical practice. From enhancing diagnostic precision to streamlining administrative workflows, AI is touted as a solution to many of health care’s long-standing inefficiencies.
It is time for the FDA to re-evaluate metrics for weight loss drugs
Between 2013 and 2016, 49.1 percent of U.S. adults surveyed had attempted to lose weight within the last 12 months. Weight loss medications have reached the public eye in popular culture and practice. To be considered effective in a clinical trial by the FDA, the drug candidate must demonstrate a statistically significant difference in mean weight loss between the active product and placebo-treated group of at least five percentage points.
The unintended consequences of centralized EHR scheduling
One of the not often discussed challenges of our EHRs may be getting patients to the right medical resource at a time most suitable for their medical condition. Our electronic systems, whether automated by algorithm or assigned to a person given a protocol have become too separated from medical care itself. Our schedulers are no longer ourselves or our secretaries trained in the variability of patient needs, which can then be reflected in physician encounters.
The unintended consequences of ERAS: Are we losing unique applicants?
Harvard police raided a dorm where 4 Black students were living after someone made a false call about an active threat: 'We are traumatized'
The unintended consequences of ERAS: Are we losing unique applicants?
Residency applicants, especially today, come from diverse backgrounds, including various careers, SESs, gap years, and geographic location. Despite an increase in applicants from diverse backgrounds, the application process may still perpetuate inequities for students and presents operational challenges for reviewing committees.
We already know how to save physicians from burnout
The foundation of modern medicine has been built on a well-established, iterative process of empirical research and the pragmatic implementation of new discoveries. A relevant example of this paradigm can be seen in the development of Pfizer’s and Moderna’s COVID-19 vaccines.
Quantitative mass spectrometric analysis of the mouse cerebral cortex after ischemic stroke
Loading metrics Open Access Peer-reviewed Research Article Ank Agarwal , Seongje Park , Shinwon Ha , Ji-Sun Kwon, Mohammed Repon Khan, Bong Gu Kang, Ted M. Dawson, Valina L. Dawson , Shaida A. Andrabi , Sung-Ung Kang Ank Agarwal, Seongje Park, Shinwon Ha, Ji-Sun Kwon, Mohammed Repon Khan, Bong Gu Kang, Ted M. Dawson, Valina L. Dawson, Shaida A.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ank
Contact Ank, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack